Innovative Bioink Technology Revolutionizes 3D Printing of Blood Vessels
November 28, 2024 - 06:05
Researchers at the University of Twente, Netherlands, have made an advancement in bioprinting technology that could transform how we create vascularized tissues. Their innovative bioink enables precise 3D printing of blood vessels, paving the way for significant improvements in regenerative medicine and tissue engineering. This breakthrough could lead to enhanced methods for developing artificial organs and improving transplant success rates. The technology utilizes DNA-based materials to create a more accurate and functional representation of vascular structures, which are crucial for supplying nutrients and oxygen to tissues. As this research progresses, it holds the potential to greatly impact healthcare and the future of medical treatments.
MORE NEWS
January 25, 2026 - 22:41
Ukrainian radio technology expert appointed as adviser to defence ministerIn a move to bolster technological innovation within the military, Serhii `Flash` Beskrestnov, a prominent Ukrainian expert in radio technology, has been appointed as an adviser to Defence Minister...
January 24, 2026 - 19:55
What Does Tactile Systems Technology, Inc.'s (NASDAQ:TCMD) Share Price Indicate?While Tactile Systems Technology, Inc. (NASDAQ:TCMD) might not have the largest market cap around, it saw a significant share price rise on the NASDAQGS recently. This movement has brought the...
January 24, 2026 - 09:04
Drones and explosives — How Alaska is using technology to manage extreme weather eventsThe state of Alaska is pioneering a high-tech approach to managing the increasing threat of extreme weather events, deploying drones and controlled explosives in a bid to enhance public safety....
January 23, 2026 - 20:22
Kyndryl Partners with Hertz on Technology TransformationKyndryl has announced a significant five-year extension of its strategic partnership with The Hertz Corporation. This renewed collaboration is centered on accelerating Hertz`s ongoing technology...